Republic Technologies Inc. (CSE:DOCT)
0.4900
0.00 (0.00%)
Oct 10, 2025, 12:36 PM EDT
Republic Technologies Statistics
Total Valuation
CSE:DOCT has a market cap or net worth of CAD 5.69 million. The enterprise value is 6.60 million.
Market Cap | 5.69M |
Enterprise Value | 6.60M |
Important Dates
The next estimated earnings date is Wednesday, November 26, 2025.
Earnings Date | Nov 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 32.49M |
Shares Outstanding | n/a |
Shares Change (YoY) | +96.25% |
Shares Change (QoQ) | +105.64% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 16.90M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -20.48 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.32 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.92
Current Ratio | 0.92 |
Quick Ratio | 0.05 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.87 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -28.67% |
Return on Invested Capital (ROIC) | -233.85% |
Return on Capital Employed (ROCE) | 266.99% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,533.33% in the last 52 weeks. The beta is 7,850.97, so CSE:DOCT's price volatility has been higher than the market average.
Beta (5Y) | 7,850.97 |
52-Week Price Change | +1,533.33% |
50-Day Moving Average | 0.57 |
200-Day Moving Average | 0.36 |
Relative Strength Index (RSI) | 35.87 |
Average Volume (20 Days) | 63,885 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 7.55 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -742,152 |
Pretax Income | -1.99M |
Net Income | -1.99M |
EBITDA | n/a |
EBIT | -742,152 |
Earnings Per Share (EPS) | -0.13 |
Balance Sheet
The company has 161,835 in cash and 1.05 million in debt, giving a net cash position of -888,832.
Cash & Cash Equivalents | 161,835 |
Total Debt | 1.05M |
Net Cash | -888,832 |
Net Cash Per Share | n/a |
Equity (Book Value) | -277,971 |
Book Value Per Share | -0.01 |
Working Capital | -277,971 |
Cash Flow
Operating Cash Flow | -362,740 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:DOCT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -96.25% |
Shareholder Yield | n/a |
Earnings Yield | -34.95% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 0.1.
Last Split Date | Dec 30, 2022 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |